<DOC>
	<DOCNO>NCT01165736</DOCNO>
	<brief_summary>The purpose study calculate pharmacokinetics ( concentration compound rate excretion blood ) follow low dose compound pharmacological activity monitor safety tolerability compound study .</brief_summary>
	<brief_title>To Calculate Pharmacokinetics ( Concentration Compound Rate Excretion From Blood ) Following Very Low Dose Compound Which Will Not Have Any Pharmacological Activity</brief_title>
	<detailed_description />
	<criteria>healthy male subject age 18 50 year inclusive . ( healthy define clinically relevant abnormality identify detailed medical history , full physical examination include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) Body Mass Index ( BMI ) 17.5 30.5kg/m2l total body weight 50 100kg inclusive . Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect trial . Evidence history clinically significant haematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , genitourinary , psychiatric , neurologic allergic disease ( include drug allergy , exclude untreated , symptomatic , seasonal allergy time dose ) History febrile illness within 5 day prior first dose positive urine drug screen</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>Chronic Pain</keyword>
</DOC>